Erratum: Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates (Nat. Biotechnol., (2018) 36, (597-605), 10.1038/nbt.4162);Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates

Nature Biotechnology

Volumn 36, Issue 7, 2018, Pages 597-605

  Liu, Yen Wen ^a,b,g   Chen, Billy ^a   Yang, Xiulan ^a   Fugate, James A ^a   Kalucki, Faith A ^a   Futakuchi Tsuchida, Akiko ^a   Couture, Larry ^c,g   Vogel, Keith W ^a   Astley, Clifford A ^a   Baldessari, Audrey ^a   Ogle, Jason ^a   Don, Creighton W ^a   Steinberg, Zachary L ^a   Seslar, Stephen P ^a   Tuck, Stephanie A ^a,h   Tsuchida, Hiroshi ^a   Naumova, Anna V ^a,d,e   Dupras, Sarah K ^a   Lyu, Milly S ^d   Lee, James ^a   Hailey, Dale W ^a   Reinecke, Hans ^a   Pabon, Lil ^a   Fryer, Benjamin H ^a   MacLellan, W Robb ^a   Thies, R Scott ^a   Murry, Charles E ^a,f   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e TOMSK STATE UNIVERSITY   (Russian Federation)

^f University of Washington   (United States)

^g NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^h Uptake Medical Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART; IMAGE SEGMENTATION; MAMMALS; PHYSIOLOGICAL MODELS; RESTORATION;

ELECTRICAL MAPPING; HUMAN EMBRYONIC STEM CELLS; LEFT VENTRICULAR EJECTION FRACTION; LEFT VENTRICULAR FUNCTION; MYOCARDIAL INFARCTION; PLURIPOTENT STEM CELLS; VENTRICULAR ARRHYTHMIAS; VENTRICULAR MYOCYTES;

STEM CELLS;

ABATACEPT; ACICLOVIR; CEFAZOLIN; CEFTAZIDIME; CYCLOSPORINE; FLUCONAZOLE; GENTAMICIN; METHYLPREDNISOLONE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL THERAPY; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO; GRAFT REJECTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; MACACA NEMESTRINA; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; ANIMAL; CARDIAC MUSCLE; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENETICS; MACACA; PATHOLOGY; PLURIPOTENT STEM CELL; PRIMATE; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; HUMAN EMBRYONIC STEM CELLS; HUMANS; MACACA; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; PRIMATES;

EID: 85049759746     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0918-899a     Document Type: Erratum

References (46)

1. Forouzanfar, M.H. et al. Assessing the global burden of ischemic heart disease, part 2: Analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob. Heart 7, 331-342 (2012).
2. Laflamme, M.A., Murry, C.E. Heart regeneration. Nature 473, 326-335 (2011).
3. Eschenhagen, T. et al. Cardiomyocyte regeneration: A consensus statement. Circulation 136, 680-686 (2017).
4. Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
5. Soonpaa, M.H., Field, L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 83, 15-26 (1998).
6. van Berlo, J.H. et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014).
7. Burridge, P.W., Sharma, A., Wu, J.C. Genetic and epigenetic regulation of human cardiac reprogramming and differentiation in regenerative medicine. Annu. Rev. Genet. 49, 461-484 (2015).
8. Gerbin, K.A., Murry, C.E. The winding road to regenerating the human heart. Cardiovasc. Pathol. 24, 133-140 (2015).
9. Lee, R.T., Walsh, K. The future of cardiovascular regenerative medicine. Circulation 133, 2618-2625 (2016).
10. Hassink, R.J. et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78, 18-25 (2008).
11. Xin, M. et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. USA 110, 13839-13844 (2013).
12. Heallen, T. et al. Hippo signaling impedes adult heart regeneration. Development 140, 4683-4690 (2013).
13. Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 (2011).
14. Shapiro, S.D. et al. Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci. Transl. Med. 6, 224ra27 (2014).
15. Leach, J.P. et al. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550, 260-264 (2017).
16. Liu, Z. et al. Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte. Nature 551, 100-104 (2017).
17. Zhou, H. et al. ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression. Genes Dev. 31, 1770-1783 (2017).
18. Cao, N. et al. Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science 352, 1216-1220 (2016).
19. Kadota, S., Pabon, L., Reinecke, H., Murry, C.E. In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Reports 8, 278-289 (2017).
20. Cho, G.S. et al. Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy. Cell. Rep. 18, 571-582 (2017).
21. van Laake, L.W. et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. (Amst.) 1, 9-24 (2007).
22. Laflamme, M.A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024 (2007).
23. Caspi, O. et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50, 1884-1893 (2007).
24. Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
25. Chong, J.J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277 (2014).
26. Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388-391 (2016).
27. Naumova, A.V., Modo, M., Moore, A., Murry, C.E., Frank, J.A. Clinical imaging in regenerative medicine. Nat. Biotechnol. 32, 804-818 (2014).
28. Zhang, W.Y., Ebert, A.D., Narula, J., Wu, J.C. Imaging cardiac stem cell therapy: Translations to human clinical studies. J. Cardiovasc. Transl. Res. 4, 514-522 (2011).
29. Chen, V.C. et al. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res. (Amst.) 15, 365-375 (2015).
30. Hohnloser, S.H., Klingenheben, T., Singh, B.N. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann. Intern. Med. 121, 529-535 (1994).
31. Chelsky, L.B. et al. Caffeine and ventricular arrhythmias. An electrophysiological approach. J. Am. Med. Assoc. 264, 2236-2240 (1990).
32. Nussbaum, J. et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J. 21, 1345-1357 (2007).
33. Kuroda, N., Tanaka, A., Ohe, C., Nagashima, Y. Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol. Int. 63, 381-390 (2013).
34. Bedada, F.B. et al. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports 3, 594-605 (2014).
35. Bergmann, O. et al. Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover. Exp. Cell Res. 317, 188-194 (2011).
36. Swijnenburg, R.J. et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112 Suppl, I166-I172 (2005).
37. Lee, A.S., Tang, C., Rao, M.S., Weissman, I.L., Wu, J.C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 19, 998-1004 (2013).
38. Hodgkinson, C.P., Bareja, A., Gomez, J.A., Dzau, V.J. Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ. Res. 118, 95-107 (2016).
39. Gerbin, K.A., Yang, X., Murry, C.E., Coulombe, K.L. Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS One 10, e0131446 (2015).
40. Zhu, K. et al. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ. Res. 122, 958-969 (2018).
41. Tachibana, A. et al. Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium. Circ. Res. 121, e22-e36 (2017).
42. Liao, S.Y. et al. Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction. Heart Rhythm 10, 273-282 (2013).
43. Liao, S.Y. et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7, 1852-1859 (2010).
44. Roell, W. et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450, 819-824 (2007).
45. Chong, J.J., Murry, C.E. Cardiac regeneration using pluripotent stem cells-progression to large animal models. Stem Cell Res. (Amst.) 13, 654-665 (2014).
46. Fernandes, S. et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J. Mol. Cell. Cardiol. 49, 941-949 (2010).